Colorado Health Network Partners with Epharmix to Improve HIV-Client Outcomes via Text Messaging
DENVER & ST. LOUIS — AUGUST 16, 2019: In an effort to hurdle the largest obstacles to effective client care — missed appointments and medication …
Digital health tool EpxCOPD prevents 1 hospitalization for every 9 patients
Researchers from Washington University School of Medicine and Saint Louis University School of Medicine found that an automated COPD telemedicine intervention delivered via phone caught …
RelateCare Partners with Epharmix to Create Powerful Patient Engagement Solution
St. Louis, MO., July, 10 2018— RelateCare, LLC, a leading healthcare communications organization, announced that it has partnered with Epharmix, the leader in evidence-based …
Text messaging tool may help fight opioid epidemic
A new automated text messaging service may curb opioid abuse and reduce the likelihood of relapse while also decreasing treatment costs, according to researchers at …
Epharmix’s behavioral health tools help partners engage vulnerable populations and improve outcomes
Helping patients with behavioral health issues manage their condition successfully is a top priority for most providers. While the term behavioral health refers to both mental …
Top accelerator Dreamit Health selects Epharmix to join its latest cohort
Top health accelerator, Dreamit Health recently selected Epharmix and six additional new companies to join its 2018 cohort. The new companies have developed innovative technology …
Missouri Governor Eric Greitens visits Epharmix during launch of Innovation Task Force report
Governor Greitens established the Governor’s Innovation Task Force (GITF) on June 19, 2017 to bring together private and public sector leaders from across the State in a …
Study: A novel patient engagement platform using accessible text messages and calls (Epharmix), maintains high patient engagement, collects and alerts providers to actionable health data
Health care providers managing patients with chronic disease recognize the need for long-term patient engagement strategies to improve compliance with therapy and treatments in between …
New publication finds EpxDiabetes helped patients reduce A1c by 1.15% in just 4 months
A newly published study in JMIR-Diabetes, found that our automated messaging intervention, EpxDiabetes helped lower HbA1c by 1.15% in just four months, while keeping patients engaged for the long-term, …
Announcing the inaugural event, Engage: A Healthcare Communication Conference
We hope you can join us for Engage: A Healthcare Communication Conference on Sept. 28th at Washington University School of Medicine. The Engage conference is sponsored …